Loading clinical trials...
Loading clinical trials...
Enhancing Fear Extinction Via Angiotensin Type 1 Receptor Inhibition: A Randomized Controlled Trial in Posttraumatic Stress Disorder
Conditions
Interventions
losartan
Placebo
Locations
6
United States
University of California, San Diego
La Jolla, California, United States
George Washington University
Washington D.C., District of Columbia, United States
Walter Reed National Military Medical Center
Bethesda, Maryland, United States
McLean Hospital
Belmont, Massachusetts, United States
Massachusetts General Hospital
Boston, Massachusetts, United States
New York University Langone Health
New York, New York, United States
Start Date
July 16, 2016
Primary Completion Date
February 29, 2020
Completion Date
September 29, 2020
Last Updated
March 12, 2021
NCT06219408
NCT07238192
NCT07317206
NCT05959434
NCT06094933
NCT06685965
Lead Sponsor
University of California, San Diego
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions